Next-generation sequencing in breast cancer: Translational science and clinical integration

Pharmacogenomics

Volumn 13, Issue 6, 2012, Pages 637-639

  Radovich, Milan ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

breast cancer; clinical; genomic oncology; genomics; next generation sequencing; transcriptomics; translational

Indexed keywords

AROMATASE INHIBITOR; ESTROGEN RECEPTOR; TRANSCRIPTOME;

BREAST CANCER; CANCER RESEARCH; COPY NUMBER VARIATION; COST; DNA REPAIR; EXOME; GENE FUSION; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENOME; HUMAN; INTEGRATION; NEXT GENERATION SEQUENCING; ONCOGENE; ONCOGENE GATA3; ONCOGENE PIK3CA; ONCOGENE RB1; ONCOGENE TP53; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

BREAST NEOPLASMS; EPIGENESIS, GENETIC; FEMALE; HUMANS; MUTATION; SEQUENCE ANALYSIS, DNA; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84859980287     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/pgs.12.18     Document Type: Review

References (18)

1. Lander ES, Linton LM, Birren B et al. Initial sequencing and analysis of the human genome. Nature 409(6822), 860-921 (2001). (Pubitemid 32165345)
2. Venter JC, Adams MD, Myers EW et al. The sequence of the human genome. Science 291(5507), 1304-1351 (2001). (Pubitemid 32173090)
3. Mardis ER. A decade's perspective on DNA sequencing technology. Nature 470(7333), 198-203 (2011).
4. Meyerson M, Gabriel S, Getz G. Advances in understanding cancer genomes through second-generation sequencing. Nat. Rev. Genet. 11(10), 685-696 (2010).
5. Ley TJ, Mardis ER, Ding L et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 456(7218), 66-72 (2008).
6. Hudson TJ, Anderson W, Artez A et al. International network of cancer genome projects. Nature 464(7291), 993-998 (2010).
7. Stephens PJ, McBride DJ, Lin ML et al. Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature 462(7276), 1005-1010 (2009).
8. Turner N, Tutt A, Ashworth A. Hallmarks of 'BRCAness' in sporadic cancers. Nat. Rev. Cancer 4(10), 814-819 (2004). (Pubitemid 39331153)
9. Farmer H, McCabe N, Lord CJ et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434(7035), 917-921 (2005). (Pubitemid 40559006)
10. Robinson DR, Kalyana-Sundaram S, Wu YM et al. Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer. Nat. Med. 17(12), 1646-1651 (2011).
11. Shah SP, Morin RD, Khattra J et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 461(7265), 809-813 (2009).
12. Ding L, Ellis MJ, Li S et al. Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 464(7291), 999-1005 (2010).
13. Navin N, Kendall J, Troge J et al. Tumour evolution inferred by single-cell sequencing. Nature 472(7341), 90-94 (2011).
14. Futreal PA. Leveraging next generation sequencing in the study of breast cancer somatic genetics. Presented at: San Antonio Breast Cancer Symposium. San Antonio, TX, USA, 8-12 December 2010.
15. Ellis MJ, Ding L, Shen D et al. Analysis of luminal-type breast cancer by massively parallel sequencing. Presented at: American Association for Cancer Research Annual Meeting. Orlando, FL, USA, 2-6 April 2011 (Abstract 87).
16. Gustin JP, Cosgrove DP, Park BH. The PIK3CA gene as a mutated target for cancer therapy. Curr. Cancer Drug Targets 8(8), 733-740 (2008).
17. O'Shaughnessy J, Craig DW, Kiefer J et al. Next generation sequencing reveals co-activating events in the MAPK and PI3K/AKT pathways in metastatic triple negative breast cancers. Presented at: San Antonio Breast Cancer Symposium. San Antonio, TX, USA, 6-10 December 2011.
18. Roychowdhury S, Iyer MK, Robinson DR et al. Personalized oncology through integrative high-throughput sequencing: a pilot study. Sci. Transl. Med. 3(111), 111-121 (2011).